glp-1 and gout Bone Fracture Risks Highlighted in New Studies GLP-1 Medications and Gout Risk:

Pharmacol Rep 2013, 65 (1), 179186

The safety has not been well studied

"FDA Response to three Citizen Petitions against biosimilars" (PDF), FDA , 30 May 2006, archived from the original (PDF) on June 19, 2006, retrieved 23 November 2015 In 2023, the FDA approved a different sustained-release form of growth hormone, Sogroya (somapacitan-beco) (Novo) for both pediatric patients (2.5 years and older) and adult patients, whom have growth failure due to inadequate secretion of endogenous growth hormone (rHGH)

Once you hit the 6-month period, or 6 total refills, take a break from B12/MIC for a minimum of 3 months

A: Using the soap daily, ideally during your regular bath routines, helps achieve the best results over time